Efficient synthesis of suitably protected β-difluoroalanine and γ-difluorothreonine from L-ascorbic acid

Organic Letters

Volumn 9, Issue 1, 2007, Pages 41-44

  Li, Gongyong ^a   Van Der Donk, Wilfred A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; DIFLUOROTHREONINE; DRUG DERIVATIVE; FLUORINE; HYDROLYASE; THREONINE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; SYNTHESIS;

ASCORBIC ACID; FLUORINE; HYDRO-LYASES; MOLECULAR STRUCTURE; THREONINE;

EID: 33846449481     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol062401a     Document Type: Article

References (68)

1. (a) Walsh, C. Tetrahedron 1982, 38, 871.
2. (b) Walsh, C. T. Annu. Rev. Biochem. 1984, 53, 493.
3. (c) Silverman, R. B. Mechanism-based Enzyme Inactivation: Chemistry and Enzymology; CRC Press: Boca Raton, FL, 1988.
4. (a) Botes, D.; Tuinman, A.; Wessels, P.; Viljoen, C.; Kruger, H.; Williams, D. H.; Santikarn, S.; Smith, R.; Hammond, S. J. Chem. Soc., Perkin Trans. 1 1984, 2311.
5. (b) Painuly, P.; Perez, R.; Fukai, T.; Shimizu, Y. Tetrahedron Lett. 1988, 29, 11.
6. (c) Dawson, R. M. Toxicon 1998, 36, 953.
7. (a) Namikoshi, M.; Rinehart, K. L. J. Industr. Microbiol. 1996, 17, 373.
8. (b) Botes, D.; Wessels, P.; Kruger, H.; Runnegar, M. T. C.; Santikarn, S.; Smith, R.; Barna, J. C. J.; Williams, D. H. J. Chem. Soc., Perkin Trans. 1 1985, 2747.
9. (c) Rinehart, K. L.; Harada, K.; Namikoshi, M.; Chen, C.; Harvis, C.; Munro, M. H. G.; Blunt, J.; Mulligan, P.; Beasley, V.; Dahlem, A.; Carmicheal, W. J. Am. Chem. Soc. 1988, 110, 8557.
10. (a) Anderson, B.; Hodgkin, D. C.; Viswamitra, M. A. Nature 1970, 225, 233.
11. (b) Walker, J.; Olesker, A.; Valente, L.; Rabanal, R.; Lukacs, G. J. Chem. Soc., Chem. Commun. 1977, 706.
12. (c) Bycroft, B. W.; Gowland, M. S. J. Chem. Soc., Chem. Commun. 1978, 256.
13. (d) Lau, R. C.; Rinehart, K. L. J. Antibiot. 1994, 47, 1466.
14. Chatterjee, C.; Paul, M.; van der Donk, W. A. Chem. Rev. 2005, 105, 633.
15. Breukink, E.; de Kruijff, B. Nat. Rev. Drug Discovery 2006, 5, 321.
16. (a) Wang, E. A.; Walsh, C. Biochemistry 1981, 20, 7539.
17. (b) Silverman, R. B.; Bichler, K. A.; Leon, A. J. J. Am. Chem. Soc. 1996, 118, 1253.
18. (b) Silverman, R. B.; Bichler, K. A.; Leon, A. J. J. Am. Chem. Soc. 1996, 118, 1241.
19. (c) Pan, Y.; Qiu, J.; Silverman, R. B. J. Med. Chem. 2003, 46, 5292.
20. (d) Berkowitz, D. B.; de la Salud-Bea, R.; Jahng, W. J. Org. Lett. 2004, 6, 1821.
21. For reviews, see: (a) Enantiocontrolled Synthesis of Fluoro-Organic Compounds; Soloshonok, V. A., Ed.; Wiley: Chichester, 1999.
22. (b) Fluorine in Bioorganic Chemistry; Welch, J. T., Eswarakrishnan, S. Eds.; Wiley: New York, 1991.
23. (c) Kollonitsch, J. In Biochemical Aspects of Fluorine Chemistry; Filler, R., Kobayashi, Y., Eds.; Kodansha Ltd. And Elsevier Biomedical: Tokyo and New York, 1982.
24. See, for example: (a) Metcalf, B. W.; Bey, P.; Danzin, C.; Jung, M. J.; Casara, P.; Vevert, J. P. J. Am. Soc. Chem. 1978, 100, 2551.
25. (b) Tsushima, T.; Kawada, K. Tetrahedron Lett. 1985, 26, 2445.
26. (c) Hart, B. P.; Coward, J. K. Tetrahedron Lett. 1993, 34, 4917.
27. (d) Shi, G.; Cai, W. J. Org. Chem. 1995, 60, 6289.
28. (e) Percy, J. M.; Prime, M. E. J. Org. Chem. 1998, 63, 8049.
29. (f) Edwards, P. D.; Andisik, D. W.; Bryant, C. A.; Ewing, B.; Gomes, B.; Lewis, J. J.; Rakiewicz, D.; Steelman, G.; Strimpler, A.; Trainor, D. A.; Tuthill, P. A.; Mauger, R. C.; Veale, C. A.; Wildonger, R. A.; Williams, J. C.; Wolanin, D. J.; Zottola, M. J. Med. Chem. 1997, 40, 1876.
30. (g) Cregge, R. J.; Durham, S. L.; Farr, R. A.; Gallion, S. L.; Hare, C. M.; Hoffman, R. V.; Janusz, M. J.; Kim, H.-O.; Koehl, J. R.; Mehdi, S.; Metz, W. A.; Peet, N. P.; Pelton, J. T.; Schreuder, H. A.; Sunder, S.; Tardif, C. J. Med. Chem. 1998, 41, 2461.
31. For asymmetric procedures, see, for example: (a) Guanti, G.; Banfi, L.; Narisano, E. Tetrahedron 1988, 44, 5553.
32. (b) Baldwin, J. E.; Lynch, G. P.; Schofield, C. J. J. Chem. Soc., Chem. Commun. 1991, 736.
33. (c) Kitazume, T.; Lin, J. T.; Yamazaki, T. Tetrahedron: Asymmetry 1991, 2, 235.
34. (d) Von dem Bussche-Huennefeld, C.; Seebach, D. Chem. Ber. 1992, 125, 1273.
35. (e) Watanabe, H.; Hashizume, Y.; Uneyama, K. Tetrahedron Lett. 1992, 33, 4333.
36. (f) Sewald, N.; Seymour, L. C.; Butrger, K.; Osipov, S. N.; Kolomiets, A.; Fokin, A. V. Tetrahedron: Asymmetry 1994, 5, 1051.
37. (g) Soloshonok, V. A. ACS Symp. Ser. 1996, 639, 26-41.
38. (h) Sakai, T.; Yan, F.; Kashino, S.; Uneyama, K. Tetrahedron 1996, 52, 233.
39. (i) Sting, A. R.; Seebach, D. Tetrahedron 1996, 52, 279.
40. (j) Arnone, A.; Bravo, P.; Capelli, S.; Fronza, G.; Meille, S. V.; Zanda, M. J. Org. Chem. 1996, 61, 3375.
41. (k) Soloshonok, V. A.; Kacharov, A. D.; Avilov, D. V.; Ishikawa, K.; Nagashima, N.; Hayashi, T. J. Org. Chem. 1997, 62, 3470.
42. (l) Demir, A. S.; Sesenoglu, O.; Gercek-Arkin, Z. Tetrahedron: Asymmetry 2001, 12, 2309.
43. (a) Zhou, H.; van der Donk, W. A. Org. Lett. 2001, 3, 593.
44. (b) Zhou, H.; Schmidt, D. M.; Gerlt, J. A.; van der Donk, W. A. Chem. Bio. Chem. 2003, 4, 1206.
45. (a) Xie, L.; Miller, L.; Chatterjee, C.; Averin, O.; Kelleher, N. L.; van der Donk, W. A. Science 2004, 303, 679.
46. (b) Li, B.; Yu, J.-P. J.; Brunzelle, J. S.; Moll, G. N.; van der Donk, W. A.; Nair, S. K. Science 2006, 311, 1464.
47. (a) Hoess, E.; Rudolph, M.; Seymour, L.; Schierlinger, C.; Burger, K. J. Fluorine Chem. 1993, 61, 163 and references therein.
48. (b) Bordusa, F.; Dahl, C.; Jakubke, H.-D.; Burger, K.; Koksch, B. Tetrahedron: Asymmetry 1999, 10, 307.
49. (c) Osipov, S. N.; Burger, K. Tetrahedron Lett. 2000, 41, 5659.
50. (d) Sani, M.; Bruche, L.; Chiva, G.; Fustero, S.; Piera, J.; Volonterio, A.; Zanda, M. Angew. Chem., Int. Ed. 2003, 42, 2060.
51. (a) Kollonitsch, J.; Marburg, S.; Perkins, L. M. J. Org. Chem. 1976, 41, 3107.
52. (b) Tsushima, T.; Kawada, K. Tetrahedron Lett. 1985, 26, 2445.
53. (c) d'Orchymont, H. Synthesis 1993, 961.
54. (d) Gerus, I. I.; Kolomeitsev, A. A.; Kolycheva, M. I.; Kukhar, V. P. J. Fluorine Chem. 2000, 105, 31.
55. (a) Fustero, S.; Navarro, A.; Pina, B.; Soler, J. G.; Bartolomé, A.; Asensio, A.; Simón, A.; Bravo, P.; Fronza, G.; Volonterio, A.; Zanda, M. Org. Lett. 2001, 3, 2621.
56. (b) Katagiri, T.; Michiharu, M.; Matsukava, Y.; Kumar, J. S. D.; Uneyama, K. Tetrahedron: Asymmetry 2001, 12, 1303.
57. (c) Abe, H.; Amii, H.; Uneyama, K. Org. Lett. 2001, 3, 313.
58. (a) Andres, G. C.; Crawford, T. C.; Bacon, B. E. J. Org. Chem. 1981, 46, 2976.
59. (b) Hubschwerlen, C. Synthesis 1986, 962.
60. Hubschwerlen, C.; Specklin, J.-L.; Higelin, J. Org. Synth. 1993, 72, 1.
61. Xu, Y.; Prestwich, G. D. J. Org. Chem. 2002, 67, 7158.
62. Mosher's amide analysis of the free amines 7a and 1a both showed an er of 1.00:0.04. See Supporting Information.
63. Both enantiomers of γ-difluoro Thr have been previously prepared in unprotected form using lipase-catalyzed resolutions: Shimizu, M.; Yokota, T.; Fujimori, K.; Fujisawa, T. Tetrahedron: Asymmetry 1993, 4, 835.
64. Dahlgren, A.; Kvarnström, I.; Vrang, L.; Hamelink, E.; Hallberg, A.; Rosenquist, A.; Samuelsson, B. Bioorg. Med. Chem. 2003, 11, 827.
65. (a) Abeles, R. H.; Alston, T. A. J. Biol. Chem. 1990, 265, 16705-16708.
66. (b) Filler, R.; Kobayashi, Y.; Yagupolskii, L. M. Organofluorine Compounds in Medicinal Chemistry and Biomedical Applications; Elsevier: New York, 1993.
67. (c) Ojima, I.; Welch, J. T.; McCarthy, J. R. Biomedical Frontiers of Fluorine Chemistry, American Chemical Society: Washington DC, 1996.
68. Imperiali, B. Adv. Biotechnol. Processes 1988, 10, 97-129.